Stocks and securities in focus
| Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc. | 5.980% | -3.301% | -30.628% | -8.846% | 24.261% | -56.185% | 69.727% |
| Novavax Inc. | 1.230% | 175.059% | 201.626% | 55.823% | 172.072% | -87.763% | 85.749% |
| Nanostr.technol. | -7.950% | - | - | - | - | - | - |
| Myriad Genetics | -0.860% | 24.324% | 21.693% | 42.857% | 29.944% | 10.897% | -4.027% |
| MacroGenics Inc. | 2.710% | -71.437% | -75.418% | -38.545% | -54.933% | -83.058% | - |
| Iovance Biotherapeutics Inc. | 0.990% | -21.783% | -13.130% | 46.274% | 29.226% | -50.684% | - |
| Insmed Inc. | -3.280% | -1.667% | -9.231% | 38.012% | -17.483% | 8.257% | -3.575% |
| HCA Holdings Inc. | -3.200% | 2.119% | -3.130% | 15.430% | 20.196% | 71.129% | 161.101% |
| Gritstone Oncology Inc | 0.140% | -19.921% | -9.684% | -67.044% | -61.598% | -89.515% | - |
| Fibrogen Inc. | -3.990% | -0.046% | -11.858% | -93.283% | 25.756% | -93.709% | - |
| Fate Therapeutics Inc. | 5.480% | 1.613% | -29.219% | -16.205% | 8.043% | -93.334% | - |
| Emergent Biosolutions Inc. | -3.840% | 34.832% | 156.400% | -41.124% | 123.429% | -89.749% | -87.739% |
| Cytomx Therapeutics Inc | -1.260% | -57.097% | -13.343% | 6.785% | 25.143% | -73.349% | - |
| Coherus Bioscien. | -3.720% | -6.074% | -7.996% | -57.187% | -36.414% | -83.191% | -87.576% |
| Chromadex Corp | 0.630% | -9.714% | -17.277% | 135.821% | 135.821% | -42.545% | - |
| CareCloud Inc. | 89.660% | 130.366% | 109.524% | -25.170% | 51.724% | -65.517% | - |
| Cardiff Oncology Inc. | 3.660% | 0.155% | -38.593% | 106.786% | 145.441% | -53.857% | -7.714% |
| Biolife Solutions Inc | 14.550% | 15.244% | 19.620% | 13.855% | 26.846% | -21.901% | 27.668% |